D1268 | 1h-benzimidazol-5-amine-2-4-aminophenyl
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| S,N-GLYCEROPHOSPHATE SHUTTLE | ∼2.5 µM | rat | skeletal muscle mitochondria | measurement of superoxide/H2O2 production | affect | 162 | ||
| Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| Glycerol-3-phosphate dehydrogenase, mitochondrial | ∼2.5 µM | rat | skeletal muscle mitochondria | measurement of superoxide/H2O2 production | inhibitor | 162 | ||
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
Aggregated GHS information provided by 36 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. Reported as not meeting GHS hazard criteria by 1 of 36 companies. For more detailed information, please visit ECHA C&L website Of the 3 notification(s) provided by 35 of 36 companies with hazard statement code(s): H302 (94.29%): Harmful if swallowed [Warning Acute toxicity, oral] H312 (94.29%): Harmful in contact with skin [Warning Acute toxicity, dermal] H332 (94.29%): Harmful if inhaled [Warning Acute toxicity, inhalation] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 1H-Benzimidazol-5-amine, 2-(4-aminophenyl)- | 1H-Benzimidazol-6-amine, 2-(4-aminophenyl)- | 1H-Benzimidazol-6-amine,2-(4-aminophenyl)- |
| 2- pound 4-AMINOPHENIL)-5-AMINOBENZIMIDAZOLE | 2-(4'-amino-phenyl)-5-amino-benzimidazole | 2-(4'-aminophenyl) 5-amino benzimidazole |
| 2-(4-Amino-phenyl)-1H-benzoimidazol-5-ylamine | 2-(4-Aminophenyl)-1H-benzimidazol-2-amine | 2-(4-Aminophenyl)-1H-benzimidazol-5-amine |
| 2-(4-Aminophenyl)-1H-benzo[d]imidazol-5-amine | 2-(4-Aminophenyl)-5-aminobenzimidazole | 2-(4-aminophenyl)-1H-1,3-benzodiazol-5-amine |
| 2-(4-aminophenyl)-1H-1,3-benzodiazol-6-amine | 2-(4-aminophenyl)-3H-benzimidazol-5-amine | 2-(4-aminophenyl)-6-amino benzimidazole |
| 2-(4-aminophenyl)-6-amino-benzimidazole | 2-(4-aminophenyl)-6-aminobenzimidazole | 2-(4-aminophenyl)benzimidazole-5-ylamine |
| 2-(p-aminophenyl)-5-aminobenzimidazole | 4-(5-Amino-1H-benzimidazole-2-yl)aniline | 5-amino-2-(4-aminophenyl)benzimidazole |
| 5-amino-2-(p-aminophenyl)benzimidazole | 6-Amino-2-(4-imino-2,5-cyclohexadiene-1-ylidene)-2,3-dihydro-1H-benzimidazole | 621A865 |
| 7621-86-5 | ACT05540 | AKOS000115437 |
| AKOS000601336 | ANW-45201 | AS-66542 |
| BDBM53882 | BP-13089 | Benzimidazol-5-amine, 2-(4-aminophenyl)- |
| Benzimidazole, 5-amino-2-(p-aminophenyl)- | CBDivE_010161 | CCG-15105 |
| CHEMBL1489074 | CS-0095841 | CTK5E2602 |
| Cambridge id 5137121 | DB-003864 | DTXSID0064755 |
| EINECS 231-538-6 | EN300-02411 | FT-0699611 |
| HMS2667O03 | LS-32540 | MCULE-4375315815 |
| MLS000764524 | NCGC00245118-01 | NE11002 |
| NSC 408148 | NSC-408148 | NSC408148 |
| Oprea1_073783 | Oprea1_196638 | Oprea1_357955 |
| SBB000645 | SCHEMBL15144987 | SCHEMBL159873 |
| SMR000290129 | SR-01000389407 | SR-01000389407-1 |
| ST001543 | ST2416096 | STK266257 |
| TC-133946 | XAFOTXWPFVZQAZ-UHFFFAOYSA-N | Z56862335 |
| ZINC297475 | [4-(6-amino-1H-benzimidazol-2-yl)phenyl]amine | cid_24260 |